Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib

BACKGROUND: The anticancer properties of metformin have been suggested in numerous experimental studies and several retrospective clinical studies show that its use is associated with improved outcome of patients with cancer. However, limited data are available for patients with metastatic renal cel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Fiala, Ondřej, Ostašov, Pavel, Rozsypalová, Aneta, Hora, Milan, Šorejs, Ondřej, Šustr, Jan, Bendová, Barbora, Trávníček, Ivan, Filipovský, Jan, Fínek, Jindřich, Büchler, Tomáš
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8153069/
https://ncbi.nlm.nih.gov/pubmed/34054309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S305321
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados